NSRX — Nasus Pharma Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Nasus Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -2.15 | -1 | -1.55 | -5.86 |
| Non-Cash Items | 0.446 | -0.24 | 0.453 | 1.41 |
| Discontinued Operations | ||||
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.495 | 0.216 | 0.434 | -0.476 |
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Cash from Operating Activities | -2.42 | -2.06 | -1.33 | -9.84 |
| Capital Expenditures | — | — | — | -0.014 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -0.16 | — | — | -3 |
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -0.32 | — | — | -6.03 |
| Financing Cash Flow Items | -0.231 | 0 | -0.23 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 2.48 | 2.11 | 1.54 | 17.8 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.143 | 0.039 | 0.101 | 0.98 |